Is the psychedelic hype bubble about to burst? Might that be best for the field? In a new @JAMAPsych article w/ me, @jpotash1, & R. Griffiths, we argue for moving beyond overly negative AND positive extremes to embrace the actual evidence @JHPsychedelics https://t.co/LnkkUMO0tj

Curious about psychedelics beyond the hype? Our new Coursera course, Psychedelic Science and Medicine, offers clear, evidence-based education on how they work & who they may help. Perfect for clinicians, students, researchers, or anyone wanting reliable info in a rapidly growing

Here's the link: https://t.co/hp3wr3GZjY

Here's an article on the course and our aims:

Note that it was supposed to be entirely free when we made it but Coursera changed policies which now means only part of it is free (it's free for many who have university access)

Here's an article on the course and our aims:

Here's the link: https://t.co/hp3wr3GZjY

Announcing a new @coursera on Psychedelic Science and Medicine! From @JHPsychedelics, it provides info on psychedelic history, risks, benefits, trials, neuro, & more. Taught by Drs. @FredBarrettPhD, Garcia-Romeu, @sdpnayak, @CeydaSayali, @PraachiTiwari, Yaden, & special guests

CPCR Faculty David Yaden (@existwell) will give a talk on his book, which is now out on paperback, in Baltimore near Johns Hopkins campus. Open to the public! Thursday 11/19 at 6pm 11 E. 33rd St

Lots of discussion of the cross-sectional, retrospective survey showing evidence for metaphysical belief change after psychedelic experiences––but few know of the better quality prospective longitudinal study showing basically NO evidence for belief change! Work led by @sdpnayak

@sdpnayak @mnvrsngh @kurtjgray No paywall:

@sdpnayak @mnvrsngh No paywall:

CPCR Director @FredBarrettPhD providing opening remarks at our @SfNtweets satellite event: “...where countless previous drugs were born in the beaker and thrived on the bench, but failed to make the jump to the bedside, psychedelics are already showing potential at the clinical

Today is the day! We will be live-tweeting this exciting event. Follow along here on our @X page to hear from a variety of experts on cross-species translation in psychedelic neuroscience!

Do you live with chronic low back pain and depression? You’re not alone. Our research team at Johns Hopkins is studying whether psilocybin may help with pain and mood. If you’d like to learn more or see if you qualify, visit the link below. https://t.co/yDHyX2RZRM You may

Dr. David Yaden will be speaking at the 5th Annual Conference on Psychedelics and Psychedelic Medicine, hosted by the Massachusetts General Hospital Psychiatry Academy, November 14–15 | Virtually via ZOOM. This two-day event highlights the most current evidence, research, and

@sdpnayak @mnvrsngh Much less discussed, but much higher quality design showing NO effect of psychedelic experience on metaphysical beliefs (though intriguing mind perception finding to follow up on @kurtjgray). led by @sdpnayak https://t.co/PWf2qbtDDn

The survey findings I often hear discussed: https://t.co/md0uPoyxkI also led by @sdpnayak and w/ @mnvrsngh

Lots of discussion of the cross-sectional, retrospective survey showing evidence for metaphysical belief change after psychedelic experiences––but few know of the better quality prospective longitudinal study showing basically NO evidence for belief change! Work led by @sdpnayak

The new journal EXPERIMENTAL PHILOSOPHY will soon be accepting submissions!

New article published in @JAMAHealthForum that examines and critiques 4 aspects of the current pathwork of regulations covering access to psychedelics––and then provides constructive, sensible, and actionable ways forward for each. Work led by drug policy expert @CaleighPropes